{"abstract":"The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled \"Development of Non-Opioid Analgesics for Acute Pain.\" In connection with the SUPPORT for Patients and Communities Act (SUPPORT Act), the purpose of this guidance is to spur the development of alternatives to opioids for the management of acute pain by providing information about product development-related issues, \"opioid-sparing\" claims, and expedited programs as they pertain to this purpose.","action":"Notice of availability.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2022/02/10/2022-02858.html","cfr_references":[],"citation":"87 FR 7843","comment_url":null,"comments_close_on":"2022-04-11","correction_of":null,"corrections":[],"dates":"Submit either electronic or written comments on the draft guidance by April 11, 2022 to ensure that the Agency considers your comment on this draft guidance before it begins work on the final version of the guidance.","disposition_notes":null,"docket_ids":["Docket No. FDA-2021-N-0556"],"dockets":[{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":15,"comment_start_date":"2022-02-10","updated_at":"2023-02-28T12:28:24.811-05:00","comment_url":"https://www.regulations.gov/commenton/FDA-2021-N-0556-0001","allow_late_comments":null,"id":"FDA-2021-N-0556-0001","comment_end_date":"2022-04-12","regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2021-N-0556","title":"Development of Non-Opioid Analgesics for Acute Pain; Draft Guidance for Industry; Availability"}],"document_number":"2022-02858","effective_on":null,"end_page":7844,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2022/02/10/2022-02858.xml","html_url":"https://www.federalregister.gov/documents/2022/02/10/2022-02858/development-of-non-opioid-analgesics-for-acute-pain-draft-guidance-for-industry-availability","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2022-02858?publication_date=2022-02-10","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2022-02-10/2022-02858/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":1071,"last_updated":"2026-09-22 12:15:07 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2022-02-10/pdf/2022-02858.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2022-02858.pdf?1644414338","publication_date":"2022-02-10","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2022/02/10/2022-02858.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_count":15,"agency_id":"FDA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2021-N-0556","supporting_documents_count":0,"docket_id":"FDA-2021-N-0556","document_id":"FDA-2021-N-0556-0001","regulation_id_number":null,"title":"Development of Non-Opioid Analgesics for Acute Pain; Draft Guidance for Industry; Availability","checked_regulationsdotgov_at":"2023-02-28T17:28:23Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":7843,"subtype":null,"title":"Development of Non-Opioid Analgesics for Acute Pain; Draft Guidance for Industry; Availability","toc_doc":"Development of Non-Opioid Analgesics for Acute Pain","toc_subject":"Guidance:\n","topics":[],"type":"Notice","volume":87}